Increased IL17 levels correlate with tumor recurrence, metastasis, and poor survival in pre-clinical models and NSCLC patients by enhancing VEGF-mediated angiogenesis in a STAT3-dependent manner [185,186,187,188]. This evidence concerns the gene VEGFA and non-small cell lung carcinoma.